- Home
- MERC vs PALI Comparison
MERC vs PALI Comparison
Compare MERC & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- PALI
- Stock Information
- Founded
- MERC 1968
- PALI 1996
- Country
- MERC Canada
- PALI United States
- Employees
- MERC N/A
- PALI N/A
- Industry
- MERC Paper
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MERC Basic Materials
- PALI Health Care
- Exchange
- MERC Nasdaq
- PALI Nasdaq
- Market Cap
- MERC 190.9M
- PALI 212.0M
- IPO Year
- MERC 1987
- PALI N/A
- Fundamental
- Price
- MERC $2.60
- PALI $1.66
- Analyst Decision
- MERC Hold
- PALI Strong Buy
- Analyst Count
- MERC 3
- PALI 2
- Target Price
- MERC $4.67
- PALI $12.00
- AVG Volume (30 Days)
- MERC 503.8K
- PALI 18.7M
- Earning Date
- MERC 11-06-2025
- PALI 11-11-2025
- Dividend Yield
- MERC 8.62%
- PALI N/A
- EPS Growth
- MERC N/A
- PALI N/A
- EPS
- MERC N/A
- PALI N/A
- Revenue
- MERC $1,951,044,000.00
- PALI N/A
- Revenue This Year
- MERC N/A
- PALI N/A
- Revenue Next Year
- MERC $13.33
- PALI N/A
- P/E Ratio
- MERC N/A
- PALI N/A
- Revenue Growth
- MERC N/A
- PALI N/A
- 52 Week Low
- MERC $2.37
- PALI $0.53
- 52 Week High
- MERC $8.28
- PALI $3.54
- Technical
- Relative Strength Index (RSI)
- MERC 43.70
- PALI 56.54
- Support Level
- MERC $2.37
- PALI $1.61
- Resistance Level
- MERC $2.72
- PALI $1.78
- Average True Range (ATR)
- MERC 0.12
- PALI 0.20
- MACD
- MERC 0.02
- PALI -0.05
- Stochastic Oscillator
- MERC 47.66
- PALI 18.06
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.